NCT06329531 2026-04-16
Validation of the Screen of Cancer Survivorship - Occupational Therapy Services (SOCS-OTS) Tool for Use in a Physical Medicine Rehabilitation Clinic
M.D. Anderson Cancer Center
Recruiting
Clinical Trials
586 trialsNCT06959706 2026-04-16
Study Evaluating the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of TGW101 in Participants With Advanced Solid Tumors
Tagworks Pharmaceuticals BV
Phase 1 Recruiting
NCT07326800 2026-04-16
MAEva-MCT
Institut de Cancérologie de Lorraine
Phase NA Recruiting
NCT04452825 2026-04-15
A New Psychotherapy Intervention for Older Cancer Patients
Memorial Sloan Kettering Cancer Center
Phase NA Recruiting
NCT05376891 2026-04-15
Met Non Small Cell Cancer Registry (MOMENT)
EMD Serono
Recruiting
NCT07005102 2026-04-15
A Study to Assess Adverse Events, Change in Disease Activity of Intravenous Telisotuzumab Adizutecan in Combination With Osimertinib as First-Line Treatment in Adult Participants With Locally Advanced Unresectable or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
AbbVie
Phase 2/3 Recruiting
NCT07342335 2026-04-15
Breaking Barriers to Research Access
The Clatterbridge Cancer Centre NHS Foundation Trust
Recruiting
NCT07528547 2026-04-15
Peds Ethos
University Health Network, Toronto
Phase NA Recruiting
NCT07532018 2026-04-15
DXP-106
Singlomics (Beijing DanXu) Biopharmaceuticals Co., Ltd.
Phase 1 Recruiting
NCT07532083 2026-04-15
Implementing AI-Assisted, Patient-Friendly Imaging Report Summaries to Enhance Oncology Care Delivery
University of Wisconsin, Madison
Recruiting
NCT00026650 2026-04-14
Evaluation of Late Effects and Natural History of Disease in Patients Treated With Radiotherapy
National Institutes of Health Clinical Center (CC)
Recruiting
NCT05088395 2026-04-14
ALCINA4
Institut Curie
Phase NA Recruiting
NCT05350761 2026-04-14
Rare Tumors and Cancer Predisposition in Individuals and Families
National Institutes of Health Clinical Center (CC)
Recruiting
NCT05382559 2026-04-14
A Study of ASP3082 in Adults With Advanced Solid Tumors
Astellas Pharma Inc
Phase 1 Recruiting
NCT06150157 2026-04-14
A Study of JNJ-88549968 for the Treatment of Calreticulin (CALR)-Mutated Myeloproliferative Neoplasms
Janssen Research & Development, LLC
Phase 1 Recruiting
NCT07527416 2026-04-14
Testi AYA
Centro di Riferimento Oncologico - Aviano
Recruiting
NCT05120596 2026-04-13
First in Human Study of T3P-Y058-739 (T3P)
T3 Pharmaceuticals AG
Phase 1/2 Recruiting
NCT05465161 2026-04-13
StingMark
Centre hospitalier de l'Université de Montréal (CHUM)
Phase NA Recruiting
NCT05862285 2026-04-13
UmbrellaMAX
Hoffmann-La Roche
Phase 3 Recruiting
NCT05879146 2026-04-13
Evaluation of the Response and Non-response of Nirogacestat in Desmoid Tumors- Clinical Study
M.D. Anderson Cancer Center
Phase 2 Recruiting
NCT06178614 2026-04-13
A Study of JNJ-87890387 for Advanced Solid Tumors
Janssen Research & Development, LLC
Phase 1 Recruiting
NCT06319378 2026-04-13
CAPSI
Section for Affective Disorders; Northern Stockholm Psychiatry
Phase 2 Recruiting
NCT06609473 2026-04-13
CHEF
Dana-Farber Cancer Institute
Phase NA Recruiting
NCT06941272 2026-04-13
MK-9999-01C
Merck Sharp & Dohme LLC
Phase 1/2 Recruiting
NCT06979596 2026-04-13
OMAHA-015
Merck Sharp & Dohme LLC
Phase 2 Recruiting
NCT07196241 2026-04-13
Comprehensive Care for AYA: Needs Assessment Survey
Wake Forest University Health Sciences
Recruiting
NCT07209111 2026-04-13
KANDLELIT-014
Merck Sharp & Dohme LLC
Phase 2 Recruiting
NCT07247110 2026-04-13
A Clinical Study of MK-4716 in People With Certain Solid Tumors (MK-4716-001)
Merck Sharp & Dohme LLC
Phase 1 Recruiting
NCT02986048 2026-04-09
Proton Therapy Patient Registry
Case Comprehensive Cancer Center
Recruiting
NCT06555744 2026-04-09
A Study of ZW191 in Participants With Solid Tumors
Zymeworks BC Inc.
Phase 1 Recruiting
NCT02090530 2026-04-08
Precision Cancer Medicine for Advanced Cancer Through High-throughput Sequencing
Ohio State University Comprehensive Cancer Center
Recruiting
NCT03366116 2026-04-08
5-aza-4'-Thio-2'-Deoxycytidine (Aza-TdC) in People With Advanced Solid Tumors
National Institutes of Health Clinical Center (CC)
Phase 1 Recruiting
NCT07284589 2026-04-08
Ultralow Dose PET Imaging of SSTR2 Radiotracer Uptake
Nuclear Imaging Institute
Phase 2 Recruiting
NCT07461493 2026-04-08
CSSI
National Minority Quality Forum
Recruiting
NCT04242095 2026-04-07
Collection of Research Data and Samples From Patients Who Experience Immunotherapy Side Effects
Alliance for Clinical Trials in Oncology
Recruiting
NCT06008392 2026-04-07
INTERCEPTioN
Mayo Clinic
Recruiting
NCT06593522 2026-04-07
A Phase 2 Study of Anvumetostat in Participants With MTAP-deleted Advanced NSCLC (MTAPESTRY 201)
Amgen
Phase 2 Recruiting
NCT06997029 2026-04-07
A Phase 1 Study of BMS-986500 as Monotherapy or Combination Therapy in Advanced Solid Tumors
Bristol-Myers Squibb
Phase 1 Recruiting
NCT00896935 2026-04-06
Arizona Cancer Center Biospecimen Repository
University of Arizona
Recruiting
NCT05781555 2026-04-06
Alpha Radiation Emitters Device (DaRT) for Target Treatments of Malignant Tumors
Alpha Tau Medical LTD.
Phase NA Recruiting
NCT06962995 2026-04-06
Multi-Cancer Detection Observational Cohort Study
Mayo Clinic
Recruiting
NCT06999785 2026-04-06
OXYBAR
University Hospital, Angers
Phase NA Recruiting
NCT07438782 2026-04-06
First Time in Human (FTIH) Study to Investigate the Safety and Preliminary Activity of GSK5533524 Alone or in Combination in Adult Participants With Advanced Solid Tumors
GlaxoSmithKline
Phase 1 Recruiting
NCT07510828 2026-04-06
PRISM-NK
Beijing Biotech
Phase 1/2 Recruiting
NCT07512505 2026-04-06
VITAL-PC
Our Lady's Hospice and Care Services
Recruiting
NCT04981821 2026-04-03
GO-EXCAP2
University of Rochester
Phase NA Recruiting
NCT05356182 2026-04-03
A Pilot and Feasibility Study of a Dietary Intervention With Low-protein Meals in Cancer Patients Receiving Immunotherapies
State University of New York at Buffalo
Phase NA Recruiting
NCT06237816 2026-04-03
CTNow: A Clinical Trials Education Program for Rural Cancer Patients and Oncology Providers
University of Hawaii
Phase NA Recruiting
NCT06867705 2026-04-03
RC-102
Resilience
Phase 3 Recruiting
NCT06901531 2026-04-03
LUCERNA
Astellas Pharma Inc
Phase 3 Recruiting